Delivery Order SPE2DB22D3301-SPE2DB25FZ0WB
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,615.05 to AmerisourceBergen Drug Corp for Corlanor 7.5 mg tablets (60-count units) on August 5, 2025, with completion expected by August 6, 2025. This competitively awarded, firm fixed-price contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Corlanor 5 mg tablets (60-count units) under a firm fixed-price contract valued at $1,923.54. The order was competitively awarded without set-aside designation and is scheduled for completion by August 26, 2025. AmerisourceBergen will fulfill this requirement from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary operations....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Corlanor 5 mg tablets (60-count) with a ceiling value of $3,296.56. This firm fixed price delivery order, with an ultimate completion date of August 13, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract was...
- The Defense Logistics Agency awarded a delivery order valued at $1,642.24 to AmerisourceBergen Drug Corp for the supply of Corlanor 5 mg tablets (60-count) on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. The contract represents a routine pharmaceutical procurement supporting federal medical supply needs...
- The Defense Logistics Agency awarded a $1,549.52 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Corlanor 5 mg tablets (60-count). This is a non-set-aside contract with an ultimate completion date of August 18, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- The Defense Logistics Agency awarded a $9,479.97 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Corlanor 5 mg tablets (60-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation, scheduled for completion by July 29, 2025. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Corlanor 5 mg tablets (60-count units) with a ceiling value of $7,155.48 under a firm fixed-price contract. This delivery order represents a child contract issued against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The award involved...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Corlanor 5 mg tablets (60-count packages) under a firm fixed-price contract valued at $10,749.07, with an ultimate completion date of July 25, 2025. This non-set-aside award was competitively procured and represents a single delivery order fulfillment for pharmaceutical products. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $2,457.28 for Corlanor 5 mg tablets (60-count) on September 2, 2025, with an ultimate completion date of September 3, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of pharmaceutical supply under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,643.36 to AmerisourceBergen Drug Corp for the supply of Corlanor (ivabradine) 5 mg tablets in a quantity of 60 units. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, issued on September 6, 2025, and scheduled for completion by September 8, 2025. The pharmaceutical products will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FZ0WBDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,265.42 to AmerisourceBergen Drug Corp for the supply of Corlanor 5 mg tablets (60-count) on September 11, 2025, with an ultimate completion date of September 12, 2025. This firm fixed price delivery order represents a non-competitive award issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. The order will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major pharmaceutical distributor serving federal medical procurement needs. This delivery order exemplifies the operational scope of AmerisourceBergen's relationship with the Defense Logistics Agency, through which the contractor supplies a broad portfolio of pharmaceutical products and medical commodities to support military healthcare systems and other federal agencies including the Defense Health Agency and U.S. Coast Guard. Corlanor, an ivabradine-based cardiac medication used in heart failure management, reflects the specialized pharmaceutical offerings delivered under this prime vendor contract. AmerisourceBergen's recurring delivery orders across multiple therapeutic domains demonstrate its capability as a critical vendor for sustaining the Department of Defense's medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 9/11/25 |